Clinical Trials Directory

Trials / Completed

CompletedNCT02543151

SpyGlass in Post Liver Transplant Biliary Complications.

Prospective Evaluation of SpyGlass Direct Visualization System in Post Liver Transplant Biliary Stricture.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Hospital Israelita Albert Einstein · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to describe SpyGlass choledochoscopy in patients with post orthotopic liver transplant (OLT) biliary strictures prior to endoscopic therapy and ductal changes after treatment stents.

Detailed description

A prospective observational clinical study to be conducted in Hospital Israelita Albert Einstein, a large open-access, private tertiary referral center. Consecutive eligible patients with suspected post OLT biliary complications referred to endoscopic retrograde cholangiopancreatography (ERCP) will be considered to SpyGlass as follows. In those patients with confirmed biliary stricture, SpyGlass direct choledochoscopy will be performed prior to endoscopic treatment with stents. After final stent removal, choledochoscopy will be repeated to evaluate biliary ductal mucosa.

Conditions

Interventions

TypeNameDescription
PROCEDURESpyGlass (direct visualization system) choledochoscopySpyGlass (direct visualization system) choledochoscopy procedure will be performed pre and post biliary complication treatment

Timeline

Start date
2016-03-01
Primary completion
2017-06-01
Completion
2018-10-01
First posted
2015-09-07
Last updated
2019-04-17

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02543151. Inclusion in this directory is not an endorsement.